Paul Russo

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• 34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma

  The Oncologist · 2025-10-01

• Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma

  Urologic Oncology Seminars and Original Investigations · 2025-09-05

• POS0549 Use of JAK inhibitors in medium- and small-sized vasculitides: a retrospective multicenter study

  Annals of the Rheumatic Diseases · 2025-06-01 · 1 citations

• A CHALLENGING CASE OF SEVERE MITRAL REGURGITATION TREATED WITH MITRAL VALVE REPLACEMENT IN PATIENT WITH REPAIRED TETRALOGY OF FALLOT

  European Heart Journal Supplements · 2025-05-01

• An International Delphi Consensus About Tumor Rupture During Robotic Partial Nephrectomy (Researching UnPredictable TUmor RupturE during Robotic Partial Nephrectomy—The RUPTURE Project)

  European Urology Open Science · 2025-04-15 · 4 citations

• MP28-05 MLH1 MISMATCH REPAIR PREDICTS EXCEPTIONAL RESPONDER PHENOTYPES IN CLEAR-CELL RENAL CELL CARCINOMA

  The Journal of Urology · 2025-04-08

• MP14-09 THE NATURAL HISTORY OF METASTATIC CLEAR-CELL RENAL CELL CARCINOMA MANAGED WITH LOCAL THERAPY ALONE: SHOULD EVERYONE BE RECEIVING ADJUVANT IMMUNOTHERAPY?

  The Journal of Urology · 2025-04-08

• MP28-11 GENOMIC PATTERNS OF METASTATIC EVOLUTION UNDERLYING CLINICAL COURSE OF METASTATIC CLEAR CELL RENAL CELL CARCINOMA

  The Journal of Urology · 2025-04-08

• Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases

  Urology Practice · 2025-03-14 · 4 citations

• CLINICAL AND GENOMIC CHARACTERIZATION OF A SINGLE-CENTER COHORT OF RENAL CELL CARCINOMA PATIENTS WITH KRAS MUTATION

  Urologic Oncology Seminars and Original Investigations · 2025-02-27

• CIRCULATING LEPTIN AND IMMUNE-RELATED TRANSCRIPTOMIC SIGNATURES IN TUMOR AND PERINEPHRIC OF CLEAR CELL RENAL CELL CARCINOMA PATIENTS

  Urologic Oncology Seminars and Original Investigations · 2025-02-27

• Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option

  Urology Practice · 2025-02-21

• Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma.

  Journal of Clinical Oncology · 2025-02-10

• Body Composition May Be a Novel Presurgical Risk Factor for Acute Kidney Injury among Clear Cell Renal Cell Cancer Patients Undergoing Radical Nephrectomy.

  PubMed · 2025-01-01

• Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

  Urologic Oncology Seminars and Original Investigations · 2024-11-12 · 6 citations

• Data from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell CarcinomaPreprint

  2024-10-02

• Supplementary Table S2 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma

  2024-10-02

• Supplementary Table S3 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma

  2024-10-02

• Supplementary Table S1 from Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma

  2024-10-02

• Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial

  Journal of Clinical Oncology · 2024-09-20 · 26 citations